Advisory Board March 7, 2023
WW International — more commonly known as WeightWatchers — on Monday announced it has purchased telehealth platform Sequence, positioning the company to begin selling obesity drugs like Wegovy and Ozempic.
Details on the acquisition
Sequence, which launched in 2021, serves around 24,000 members nationwide as of February, and earns around $25 million in annual revenue. Sequence is a $99 a month subscription service that provides telehealth visits with doctors who are able to prescribe obesity drugs like Wegovy, Ozempic, and Mounjaro.
These drugs work by acting like GLP-1, a hormone that occurs naturally and stimulates the production of insulin, slowing the emptying of the stomach and making users feel fuller longer.
Currently, Wegovy is approved by FDA to treat obesity...
Today's Sponsors
Today's Sponsor